Terms: = Kidney tumors AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Staging
3 results:
1. Clinical characteristics of patient selection and imaging predictors of outcome in solid tumors treated with checkpoint-inhibitors.
Rossi S; Toschi L; Castello A; Grizzi F; Mansi L; Lopci E
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2310-2325. PubMed ID: 28815334
[TBL] [Abstract] [Full Text] [Related]
2. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
[TBL] [Abstract] [Full Text] [Related]
3. [Paratesticular recurrence of renal carcinoma].
Márquez Moreno AJ; Machuca Santa Cruz J; Corral García P; Jiménez Martín J; Ortega Jiménez MV; Polo Camacho M
Arch Esp Urol; 2001 Dec; 54(10):1135-7. PubMed ID: 11852526
[TBL] [Abstract] [Full Text] [Related]
